Efficacy and Safety of Ribavirin with Sofosbuvir Plus Ledipasvir in Patients with Genotype 1 Hepatitis C: A Meta-Analysis

被引：0
|
作者：
Qiu-Feng He
Qiong-Fang Zhang
Da-Zhi Zhang
机构：
[1] Chongqing Medical University,Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, The Second Affiliated Hospital
来源：
Digestive Diseases and Sciences | 2016年 / 61卷
关键词：
Genotype 1 hepatitis C; Sofosbuvir; Ledipasvir; Ribavirin; Efficacy; Safety;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3108 / 3117
页数：9
相关论文
共 50 条
  • [41] Sofosbuvir plus ribavirin for treating Egyptian patients with hepatitis C genotype 4
    Doss, Wahid
    Shiha, Gamal
    Hassany, Mohamed
    Soliman, Reham
    Fouad, Rabab
    Khairy, Marwa
    Samir, Waleed
    Hammad, Radi
    Kersey, Kathryn
    Jiang, Deyuan
    Doehle, Brian
    Knox, Steven J.
    Massetto, Benedetta
    McHutchison, John G.
    Esmat, Gamal
    JOURNAL OF HEPATOLOGY, 2015, 63 (03) : 581 - 585
  • [42] Safety and efficacy of sofosbuvir-based medication regimens with and without ribavirin in hepatitis C patients: A systematic review and meta-analysis
    Elshafie, Shaimaa
    Trivedi-Kapoor, Rupal
    Ebell, Mark
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (08) : 1149 - 1158
  • [43] Efficacy and safety of ledipasvir/sofosbuvir therapy in HCV genotype 1 Korean patients
    Kang, Wonseok
    Sinn, Dong Hyun
    Gwak, Geum-Youn
    Paik, Yong-Han
    Choi, Moon Seok
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 194 - 194
  • [44] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 : E877 - E882
  • [45] Safety and efficacy of sofosbuvir/ledipasvir and sofosbuvir/daclatasvir in the treatment of hepatitis C in patients with decompensated cirrhosis
    El Kassas, Mohamed
    Abdeen, Nermeen
    Omran, Dalia
    Alboraie, Mohamed
    Salaheldin, Mohamed
    Eltabbakh, Mohamed
    Farghaly, Rasha
    Emadeldeen, Mohammed
    Afify, Shimaa
    Sweedy, Ahmad
    Ghalwash, Ahmed
    Abbass, Amr
    Ezzat, Sameera
    Tahoon, Marwa
    ELshazly, Helmy M.
    Hamdy, Hassan
    Omar, Heba
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2021, 33 (1S) : E877 - E882
  • [46] Safety and Efficacy of Ledipasvir and Sofosbuvir for Hepatitis C in a Community Setting
    Thukral, Chandrashekhar
    Vicari, Joseph J.
    Bernsten, Andrew
    Geissler, Kathy
    Popejoy, Sara
    GASTROENTEROLOGY, 2016, 150 (04) : S1105 - S1105
  • [47] Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Patients Aged 65 Years or Older: A Retrospective Analysis of Phase 3
    Saab, Sammy
    Mizokami, Masashi
    Omata, Masao
    Mangia, Alessandra
    Eggleton, Ed
    Seyedkazemi, Star
    Zhu, Yanni
    Knox, Steven J.
    Pang, Phil
    Subramanian, G. M.
    Kowdley, Kris
    Afdhal, Nezam H.
    GASTROENTEROLOGY, 2015, 148 (04) : S1085 - S1085
  • [48] Safety and efficacy of sofosbuvir plus ledipasvir and sofosbuvir plus daclatasvir in thalassemic adolescent patients with chronic hepatitis C: A single center observational study
    Sawant, Prabha
    Patel, Ruchir
    Pandey, Vikas
    Ingle, Meghraj
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2017, 32 : 159 - 159
  • [49] US Experience of Sofosbuvir plus Ledipasvir plus Ribavirin for 12 Weeks in Previous Treatment Experienced Genotype 1 Chronic Hepatitis C With Cirrhosis
    Hermann, John E.
    Gonzalez, Stevan
    Gautam, Manjushree
    Ashfaq, Mohammad
    Modi, Apurva A.
    GASTROENTEROLOGY, 2016, 150 (04) : S1106 - S1106
  • [50] Safety and Efficacy of Ledipasvir/Sofosbuvir for the Treatment of Genotype 1 Hepatitis C in Subjects Aged 65 Years or Older
    Saab, Sammy
    Park, Sarah H.
    Mizokami, Masashi
    Omata, Masao
    Mangia, Alessandra
    Eggleton, Ed
    Zhu, Yanni
    Knox, Steven J.
    Pang, Phil
    Subramanian, Mani
    Kowdley, Kris
    Afdhal, Nezam H.
    HEPATOLOGY, 2016, 63 (04) : 1112 - 1119
12345